William L. Bigbee

4.7k total citations
80 papers, 3.2k citations indexed

About

William L. Bigbee is a scholar working on Molecular Biology, Cancer Research and Spectroscopy. According to data from OpenAlex, William L. Bigbee has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Cancer Research and 18 papers in Spectroscopy. Recurrent topics in William L. Bigbee's work include Advanced Proteomics Techniques and Applications (17 papers), Carcinogens and Genotoxicity Assessment (12 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). William L. Bigbee is often cited by papers focused on Advanced Proteomics Techniques and Applications (17 papers), Carcinogens and Genotoxicity Assessment (12 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). William L. Bigbee collaborates with scholars based in United States, Finland and Japan. William L. Bigbee's co-authors include Ronald H. Jensen, Jill M. Siegfried, Richard G. Langlois, Anna Lokshin, Joel L. Weissfeld, Talal El‐Hefnawy, Adele Marrangoni, Ronald B. Herberman, Lyudmila Velikokhatnaya and Matthew Winans and has published in prestigious journals such as Nature, Science and Journal of Clinical Oncology.

In The Last Decade

William L. Bigbee

79 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William L. Bigbee United States 31 1.8k 878 479 469 390 80 3.2k
Horst Zitzelsberger Germany 41 2.6k 1.4× 1.3k 1.5× 990 2.1× 493 1.1× 591 1.5× 141 4.9k
Mukesh Verma United States 34 2.4k 1.3× 846 1.0× 624 1.3× 144 0.3× 413 1.1× 147 3.9k
Ronald H. Jensen United States 33 2.3k 1.3× 1.1k 1.3× 444 0.9× 436 0.9× 510 1.3× 93 3.9k
Françoise Degos France 42 1.2k 0.7× 641 0.7× 602 1.3× 237 0.5× 290 0.7× 145 9.1k
Mark Kriegsmann Germany 32 1.3k 0.7× 529 0.6× 938 2.0× 194 0.4× 545 1.4× 181 3.0k
Joanna Polańska Poland 27 1.0k 0.6× 460 0.5× 275 0.6× 382 0.8× 385 1.0× 171 2.6k
Claus Høgdall Denmark 42 1.6k 0.9× 1.1k 1.2× 1.4k 3.0× 392 0.8× 412 1.1× 284 6.0k
Dinesh Rakheja United States 42 2.9k 1.6× 1.3k 1.5× 707 1.5× 531 1.1× 1.3k 3.3× 188 6.0k
David C. Wedge United Kingdom 29 2.7k 1.5× 2.0k 2.2× 984 2.1× 109 0.2× 659 1.7× 72 5.0k
Catharine M. Sturgeon United Kingdom 25 735 0.4× 412 0.5× 623 1.3× 225 0.5× 317 0.8× 73 2.4k

Countries citing papers authored by William L. Bigbee

Since Specialization
Citations

This map shows the geographic impact of William L. Bigbee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William L. Bigbee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William L. Bigbee more than expected).

Fields of papers citing papers by William L. Bigbee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William L. Bigbee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William L. Bigbee. The network helps show where William L. Bigbee may publish in the future.

Co-authorship network of co-authors of William L. Bigbee

This figure shows the co-authorship network connecting the top 25 collaborators of William L. Bigbee. A scholar is included among the top collaborators of William L. Bigbee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William L. Bigbee. William L. Bigbee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McShane, Lisa M., Margaret M. Cavenagh, Tracy Lively, et al.. (2013). Criteria for the use of omics-based predictors in clinical trials. Nature. 502(7471). 317–320. 164 indexed citations
2.
Bigbee, William L., Vanathi Gopalakrishnan, Joel L. Weissfeld, et al.. (2012). A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening. Journal of Thoracic Oncology. 7(4). 698–708. 67 indexed citations
3.
Li, Xiaoxiao, James F. LeBlanc, Allison Truong, et al.. (2011). A Metaproteomic Approach to Study Human-Microbial Ecosystems at the Mucosal Luminal Interface. PLoS ONE. 6(11). e26542–e26542. 65 indexed citations
4.
Ostrow, Kimberly Laskie, Mohammad Obaidul Hoque, Myriam Loyo, et al.. (2010). Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR. Clinical Cancer Research. 16(13). 3463–3472. 92 indexed citations
5.
Ostroff, Rachel, William L. Bigbee, Wilbur A. Franklin, et al.. (2010). Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer. PLoS ONE. 5(12). e15003–e15003. 163 indexed citations
6.
Bennett, L. Michelle, Yun Wang, Marilyn J. Ramsey, et al.. (2010). Cigarette smoking during pregnancy: Chromosome translocations and phenotypic susceptibility in mothers and newborns. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 696(1). 81–88. 16 indexed citations
7.
Boice, John D., William L. Bigbee, Michael T. Mumma, Clark W. Heath, & William J. Blot. (2009). Cancer Incidence in Municipalities near Two Former Nuclear Materials Processing Facilities in Pennsylvania—An Update. Health Physics. 96(2). 118–127. 12 indexed citations
8.
Boice, John D., William L. Bigbee, Michael T. Mumma, Robert E. Tarone, & William J. Blot. (2009). County Mortality and Cancer Incidence in Relation to Living near Two Former Nuclear Materials Processing Facilities in Pennsylvania—An Update. Health Physics. 96(2). 128–137. 9 indexed citations
9.
Seder, Christopher W., Guoan Chen, Xiaoju Wang, et al.. (2008). AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma. Journal of Thoracic Oncology. 3(11). 1236–1244. 44 indexed citations
10.
Chen, Guoan, Xiaoju Wang, Jianjun Yu, et al.. (2007). Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma. Cancer Research. 67(7). 3461–3467. 73 indexed citations
11.
Shyr, Yu, Lisa J. Zimmerman, Bashar Shakhtour, et al.. (2007). Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer. Journal of Thoracic Oncology. 2(10). 893–901. 81 indexed citations
12.
Nukui, Tomoko, Richard Day, Heather Gordish‐Dressman, et al.. (2006). The absence of interaction between drug metabolizing enzyme genotypes and maternal lifestyle factors on glycophorin A somatic mutation frequency levels in newborns. Pharmacogenetics and Genomics. 16(2). 129–138. 3 indexed citations
13.
Keohavong, Phouthone, Liqiang Xi, Richard Day, et al.. (2005). HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of mothers exposed to tobacco smoke during pregnancy. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 572(1-2). 156–166. 22 indexed citations
14.
Grizzle, William E., Bao-Ling Adam, William L. Bigbee, et al.. (2004). Serum Protein Expression Profiling for Cancer Detection: Validation of a SELDI‐Based Approach for Prostate Cancer. Disease Markers. 19(4-5). 185–195. 52 indexed citations
15.
Scheerer, Julia B., et al.. (1999). Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 431(2). 291–303. 10 indexed citations
16.
Bigbee, William L., James C. Fuscoe, Stephen G. Grant, et al.. (1998). Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 397(2). 119–136. 28 indexed citations
17.
Manchester, David, Janice A. Nicklas, John P. O’Neill, et al.. (1995). Sensitivity of somatic mutations in human umbilical cord blood to maternal environments. Environmental and Molecular Mutagenesis. 26(3). 203–212. 24 indexed citations
18.
Helzlsouer, Kathy J., Emily Harris, R. Parshad, et al.. (1995). Familial clustering of breast cancer: Possible interaction between dna repair proficiency and radiation exposure in the development of breast cancer. International Journal of Cancer. 64(1). 14–17. 52 indexed citations
19.
Bigbee, William L., Richard G. Langlois, Larry H. Stanker, Martin Vanderlaan, & Ronald H. Jensen. (1990). Flow cytometric analysis of erythrocyte populations in tn syndrome blood using monoclonal antibodies to glycophorin A and the Tn antigen. Cytometry. 11(2). 261–271. 20 indexed citations
20.
Bigbee, William L., Andrew J. Wyrobek, Richard G. Langlois, Ronald H. Jensen, & Richard B. Everson. (1990). The effect of chemotherapy on the in vivo frequency of glycophorin A ‘null’ variant erythrocytes. Mutation Research/Genetic Toxicology. 240(3). 165–175. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026